Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
코로나바이러스 2019 질병의 예방 및 치료에 중요한 보조제로서의 정맥 면역글로불린
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adult patients
affected
attenuate
Autoimmune disease
Autoimmune diseases
Autoimmunity
benefit
caused
clinically
contributing to
control group
control groups
coronavirus
coronavirus 2019 disease
coronavirus disease
Coronavirus disease‐19
Corticosteroids
COVID‐19
COVID‐19 patients
COVID‐19
COVID‐19 vaccination
Critically ill
Cytokines
disease
early administration
Evidence
heterogeneity
ICU
Immunoglobulin
immunomodulation
immunotherapies
Immunotherapy
in some
Intravenous immunoglobulin
IVIG
lack
limitation
Long‐COVID
lung
mechanical ventilation
mechanism
morbidity and mortality
New coronavirus
outcome
pandemic
pathogenic
Patient
patients
Post‐COVID
presenting
Pulmonary function
rapid response
reduce
reduction in mortality
respiratory
SARS‐CoV‐2
severe acute respiratory syndrome Coronavirus
severe disease
syndrome
target
the disease
therapy
Treatment
vaccination
Vascular
vascular system
[DOI] 10.1111/sji.13101 PMC 바로가기 [Article Type] Review
[DOI] 10.1111/sji.13101 PMC 바로가기 [Article Type] Review